Mattress Liquidators has turned Entero Therapeutics white as a sheet. The creditor ordered Entero to repay its loan, prompting the biotech to lay off staff from the CEO down and race to find a way out ...

BOCA RATON, FL / ACCESS Newswire / October 14, 2025 / Entero Therapeutics (NASDAQ:ENTO) didn't tiptoe into reinvention. It jumped. The company, once known for enzymes and patient trials, is now in the ...

BOCA RATON, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing in the ...

Entero’s publicly‑listed platform now sits at the intersection of AI, data centers, power grids, and global infrastructure. The acquisition of Grid AI, now operating as a wholly‑owned subsidiary of ...

Entero Therapeutics, Inc. has announced a $2 million revolving loan agreement and significant changes to its Board of Directors, appointing three new members designated by the lender, following the ...

BOCA RATON, FL / ACCESS Newswire / November 6, 2025 / Entero Therapeutics, Inc. (NASDAQ:ENTO) (“ENTO” or the “Company”), the parent company of Grid AI, announced today the signing of a Letter of ...

Over the past three months, the United States has seen an unprecedented flood of new AI-data-center investments more than $60 billion in announced projects across the country. It’s the latest sign of ...

・Entero said that it will change its ticker symbol to GRDX to align with the name change. ・The name and ticker change, however, will not affect the company’s business operations or financial reporting ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

BOCA RATON, FL / ACCESS Newswire / October 30, 2025 / Entero Therapeutics, Inc. ("Entero" or the "Company") (NASDAQ:ENTO) is pleased to announce that, as a result of the acquisition of 100% of Grid AI ...